NewEdge Wealth’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
NewEdge Wealth's AMGN Position: Q2 2026 in Review
NewEdge Wealth reduced its Amgen (AMGN) stake by 25% in Q2 2026, selling an estimated $12.6M and leaving 110,074 shares worth $39.9M. The position accounts for 0.4% of the portfolio, ranked #60.
NewEdge Wealth first reported a position in AMGN in Q4 2020 and has held it in 23 quarters since. The position peaked at $51.6M in Q1 2026. 3,156 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- NewEdge Wealth held 110,074 shares of Amgen worth $39.9M as of Q2 2026.
- NewEdge Wealth sold 36,663 Amgen shares in Q2 2026, an estimated $12.6M.
- Amgen made up 0.4% of NewEdge Wealth's portfolio in Q2 2026, its #60 holding.
- NewEdge Wealth first reported a position in Amgen in Q4 2020 and has held it in 23 quarters since.
- NewEdge Wealth's Amgen position peaked at $51.6M in Q1 2026.
- 3,156 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on NewEdge Wealth's 13F filing for Q2 2026, filed 10 Aug 2026.